EARNINGS PER SHARE - Additional Information (Details) - shares |
3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
May 22, 2019 |
Sep. 26, 2020 |
Sep. 28, 2019 |
Sep. 26, 2020 |
Sep. 28, 2019 |
|
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||||
Weighted average number of shares outstanding - basic and diluted (in shares) | 56,647,561 | ||||
Anti-dilutive stock-based awards excluded from diluted calculation (in USD per share) | 1,600,000 | 300,000 | 1,100,000 | 200,000 | |
Performance Based Restricted Stock Units | |||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||||
Anti-dilutive stock-based awards excluded from diluted calculation (in USD per share) | 400,000 | 500,000 |
X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|
X | ||||||||||
- Details
|